Immune Repertoire Sequencing Market, By Product Type (Instruments, Assay Kits), By Application (Cancer Immunotherapy, Biomarker Discovery, Autoimmune Diseases, Vaccine Development and Efficacy, Transplant Rejection and Tolerance, Infectious Diseases, Others), By Country, and By Region Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
REPORT HIGHLIGHT
Immune Repertoire Sequencing Market size was valued at USD 1,315.8 million in 2022, expanding at a CAGR of 7.7% from 2023 to 2030.
Immune repertoire sequencing is a technique used to analyze the diversity and composition of the immune system's repertoire of antibodies or T cell receptors. Immune repertoire refers to all of the unique T-cell receptor and B-cell receptor genetic rearrangements within the adaptive immune system It has unique advantages compared to the more common diagnostic and prognostic techniques that predate it. The traditional strategies for studying the immune repertoire, which include spectating, Sanger sequencing et al., are laborious, costly, and insufficient for generating a high-resolution picture of the immune repertoire. For instance, specific disease prognoses can lead to the evolution of similar or identical CDR3s in different patients. CDR3 sequencing can thus potentially be used for diagnosis.
Immune Repertoire Sequencing Market- Market Dynamics
- An increase in government support for pharmacogenomics-based drug recovery is expected to propel market demand
Immune repertoire sequencing can accessory pharmacogenomics by providing additional acumens into a patient's immune system and its response to drug therapies. For example, in the perspective of cancer treatment, immune repertoire sequencing can help identify tumor-specific antigens recognized by the immune system. However, the increase in demand for immunotherapy for cancer and other infectious diseases is expected to propel the growth of the Immune Repertoire Sequencing Market. Immunotherapy drugs work better in some cancers than others and while they can be a miracle for some, they fail to work for all patients. Overall response rates are about 15 to 20%. And also there is so much pharmaceutical R&D that cancer immunotherapy has its own stock index of 25 companies worth USD100 million or more, according to Johns Hopkins Medicine.
Immune Repertoire Sequencing Market- Key Insights
- As per the analysis shared by our research analyst, the global Immune Repertoire Sequencing market is estimated to grow annually at a CAGR of around XX% over the forecast period (2023-2030)
- The Immune Repertoire Sequencing industry is projected to grow at a significant rate due to the growing awareness of sustainable growth
- Based on product type segmentation, Assay Kits was predicted to show maximum market share in the year 2022
- Based on Application segmentation, Cancer Immunotherapy was the leading type in 2022
- On the basis of region, North America was the leading revenue generator in 2022
Immune Repertoire Sequencing Market- Segmentation Analysis:
The Global Immune Repertoire Sequencing Market is segmented on the basis of Product Type, Application, Technology, and Region.
The market is divided into three categories based on product type: Instruments and Assay Kits. Assay Kits are likely to dominate the market. These kits typically include reagents and protocols for sample preparation, library construction, sequencing, and data analysis.
The market is divided into six categories based on application: Cancer Immunotherapy, Biomarker Discovery, Autoimmune Diseases, Vaccine Development and Efficacy, Transplant Rejection, and Tolerance, Infectious Diseases, and Others. Cancer Immunotherapy dominates the market and is likely to maintain its dominance during the forecast period. Cancer immunotherapy is a rapidly advancing field that utilizes the body's immune system to fight cancer.
Immune Repertoire Sequencing Market- Geographical Insights
Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to dominate the growth of the Immune Repertoire Sequencing Market, due to rising Government Funding to Improve the Healthcare Infrastructure. Medical and Health Research and Development predicted that the Federal government investment accounts for one-quarter (25%) of all U.S. medical and health R&D at USD61.5 billion, with the National Institutes of Health (NIH) alone accounting for 20% (USD48.9 billion) of all such investment in 2020. At this level, NIH is the second largest funder of medical and health research after the biopharmaceutical industry. However, Increased government funding can provide researchers and institutions with more resources to conduct research on immune repertoire sequencing. Europe and the Asia Pacific are expected to expand significant growth during the forecast period, due to increasing research and development and launches of novel products.
Immune Repertoire Sequencing Market- Competitive Landscape:
The demand for immune repertoire sequencing has been steadily increasing due to its vital role in understanding the immune system, disease progression, and developing personalized therapies. The companies provide sequencing instruments, reagents, and software solutions for immune repertoire analysis. The immune repertoire sequencing market is competitive, with a range of companies and research institutions driving innovation and providing solutions for sequencing and analyzing immune repertoires. Advancements in sequencing technologies, bioinformatics tools, and data analysis methods continue to shape the competitive landscape and contribute to the growth of the market. For example, in 2023, Thermo Fisher Scientific announced a new suite of Ion Torrent Oncomine immune repertoire assays designed to detect potentially malignant clones of T-cells and B-cells, which play a key role in the immune response system.
Recent Developments:
- Pfizer Inc. and Adaptive Biotechnologies Corporation have entered into a translational research collaboration to leverage next-generation sequencing of the adaptive immune system to advance Pfizer’s growing immuno-oncology franchise. Under the terms of the agreement, Pfizer and Adaptive will seek to combine drug development and platform technology biomarker expertise to identify patients who may preferentially benefit from immunotherapy.
Key features of the study:
- This proposed research study on Immune Repertoire Sequencing market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year
- The report provides the client the latest up-to-date and trending insights about the Immune Repertoire Sequencing market.
- The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for Immune Repertoire Sequencing market
- The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Immune Repertoire Sequencing market
- Impact of COVID-19 on Immune Repertoire Sequencing market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on Immune Repertoire Sequencing market post-COVID will also be covered.
- In order to give the users of this report a comprehensive view on the Immune Repertoire Sequencing market, we have also included competitive landscape and key innovator analysis for the Immune Repertoire Sequencing market.
- The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
- The report offers detailed company profiling featuring major market participants which will help users to understand their financial information and strategic initiatives of players operating in the Immune Repertoire Sequencing market.
- In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
- The global Immune Repertoire Sequencing market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL IMMUNE REPERTOIRE SEQUENCING MARKET KEY PLAYERS
- Illumina Inc.
- Thermo Fisher Scientific
- PacBio
- CD Genomics
- Agilent Technologies, Inc
- Hoffmann-La Roche Ltd
- BGI Group Guangdong
- Takara Bio, Inc.
- Adaptive Biotechnologies
- Juno Therapeutics
- Atreca, Inc.
- irepertoire, Inc.
GLOBAL IMMUNE REPERTOIRE SEQUENCING MARKET, BY PRODUCT TYPE
- Instruments
- Assay Kits
GLOBAL IMMUNE REPERTOIRE SEQUENCING MARKET, BY APPLICATION
- Cancer Immunotherapy
- Biomarker Discovery
- Autoimmune Diseases
- Vaccine Development and Efficacy
- Transplant Rejection and Tolerance
- Infectious Diseases
- Others
GLOBAL IMMUNE REPERTOIRE SEQUENCING MARKET, BY REGION
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Immune Repertoire Sequencing Market Overview
1.1. Study Scope
2. Executive Summary
2.1. Market Snippet
2.1.1. Immune Repertoire Sequencing Market Snippet by Product Type
2.1.2. Immune Repertoire Sequencing Market Snippet by Application
2.1.3. Immune Repertoire Sequencing Market Snippet by Country
2.1.4. Immune Repertoire Sequencing Market Snippet by Region
2.2. Competitive Insights
3. Immune Repertoire Sequencing Key Market Trends
3.1. Immune Repertoire Sequencing Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Immune Repertoire Sequencing Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Immune Repertoire Sequencing Market Opportunities
3.4. Immune Repertoire Sequencing Market Future Trends
4. Immune Repertoire Sequencing Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Immune Repertoire Sequencing Market: COVID-19 Impact Analysis
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. Immune Repertoire Sequencing Market Landscape
6.1. Immune Repertoire Sequencing Market Share Analysis, 2022
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Immune Repertoire Sequencing Market – By Product Type
7.1. Overview
7.1.1. Segment Share Analysis, By Product Type, 2022 & 2030 (%)
7.1.2. Instruments
7.1.3. Assay Kits
8. Immune Repertoire Sequencing Market – By Application
8.1. Overview
8.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
8.1.2. Cancer Immunotherapy
8.1.3. Biomarker Discovery
8.1.4. Autoimmune Diseases
8.1.5. Vaccine Development and Efficacy
8.1.6. Transplant Rejection and Tolerance
8.1.7. Infectious Diseases
8.1.8. Others
9. Immune Repertoire Sequencing Market– By Geography
9.1. Introduction
9.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
9.2. North America
9.2.1. Overview
9.2.2. Immune Repertoire Sequencing Key Manufacturers in North America
9.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
9.2.4. North America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.2.6. U.S.
9.2.6.1. Overview
9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.2.6.3. U.S. Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.2.6.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.2.7. Canada
9.2.7.1. Overview
9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.2.7.3. Canada Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.2.7.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.3. Europe
9.3.1. Overview
9.3.2. Immune Repertoire Sequencing Key Manufacturers in Europe
9.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
9.3.4. Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.3.6. Germany
9.3.6.1. Overview
9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.3.6.3. Germany Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.3.6.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.3.7. Italy
9.3.7.1. Overview
9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.3.7.3. Italy Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.3.7.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.3.8. United Kingdom
9.3.8.1. Overview
9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.3.8.3. United Kingdom Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.3.8.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.3.9. France
9.3.9.1. Overview
9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.3.9.3. France Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.3.9.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.3.10. Russia
9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.3.10.2. Russia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.3.10.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.3.11. Netherlands
9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.3.11.2. Netherlands Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.3.11.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.3.12. Sweden
9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.3.12.2. Sweden Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.3.12.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.3.13. Poland
9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.3.13.2. Poland Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.3.13.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.3.14. Rest of Europe
9.3.14.1. Overview
9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.3.14.3. Rest of the Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.3.14.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.4. Asia Pacific (APAC)
9.4.1. Overview
9.4.2. Immune Repertoire Sequencing Key Manufacturers in Asia Pacific
9.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
9.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.4.6. India
9.4.6.1. Overview
9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.4.6.3. India Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.4.6.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.4.7. China
9.4.7.1. Overview
9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.4.7.3. China Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.4.7.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.4.8. Japan
9.4.8.1. Overview
9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.4.8.3. Japan Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.4.8.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.4.9. South Korea
9.4.9.1. Overview
9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.4.9.3. South Korea Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.4.9.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.4.10. Australia
9.4.10.1. Overview
9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.4.10.3. Australia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.4.10.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.4.11. Thailand
9.4.11.1. Overview
9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.4.11.3. Thailand Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.4.11.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.4.12. Indonesia
9.4.12.1. Overview
9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.4.12.3. Indonesia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.4.12.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.4.13. Philippines
9.4.13.1. Overview
9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.4.13.3. Philippines Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.4.13.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.4.14. Rest of APAC
9.4.14.1. Overview
9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.4.14.3. Rest of APAC Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.4.14.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.5. Latin America
9.5.1. Overview
9.5.2. Immune Repertoire Sequencing Key Manufacturers in Latin America
9.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
9.5.4. Latin America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.5.6. Brazil
9.5.6.1. Overview
9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.5.6.3. Brazil Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.5.6.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.5.7. Mexico
9.5.7.1. Overview
9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.5.7.3. Mexico Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.5.7.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.5.8. Argentina
9.5.8.1. Overview
9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.5.8.3. Argentina Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.5.8.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.5.9. Colombia
9.5.9.1. Overview
9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.5.9.3. Colombia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.5.9.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.5.10. Rest of LATAM
9.5.10.1. Overview
9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.5.10.3. Rest of LATAM Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.5.10.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.6. Middle East and Africa
9.6.1. Overview
9.6.2. Immune Repertoire Sequencing Key Manufacturers in Middle East and Africa
9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
9.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.6.6. Saudi Arabia
9.6.6.1. Overview
9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.6.6.3. Saudi Arabia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.6.6.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.6.7. United Arab Emirates
9.6.7.1. Overview
9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.6.7.3. United Arab Emirates Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.6.7.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.6.8. Israel
9.6.8.1. Overview
9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.6.8.3. Israel Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.6.8.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.6.9. Turkey
9.6.9.1. Overview
9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.6.9.3. Turkey Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.6.9.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.6.10. Algeria
9.6.10.1. Overview
9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.6.10.3. Algeria Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.6.10.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.6.11. Egypt
9.6.11.1. Overview
9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.6.11.3. Egypt Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.6.11.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.6.12. Rest of MEA
9.6.12.1. Overview
9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.6.12.3. Rest of MEA Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.6.12.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10. Key Vendor Analysis- Immune Repertoire Sequencing Industry
10.1. Competitive Dashboard
10.2. Company Profiles
10.2.1. Illumina Inc.
10.2.2. Thermo Fisher Scientific
10.2.3. PacBio
10.2.4. CD Genomics
10.2.5. Agilent Technologies, Inc
10.2.6. F. Hoffmann-La Roche Ltd
10.2.7. BGI Group Guangdong
10.2.8. Takara Bio, Inc.
10.2.9. Adaptive Biotechnologies
10.2.10. Juno Therapeutics
10.2.11. Atreca, Inc.
10.2.12. irepertoire, Inc.
11. 360 Degree Analyst View
12. Appendix
12.1. Research Methodology
12.2. References
12.3. Abbreviations
12.4. Disclaimer
12.5. Contact Us
